02.11.2017 20:11:00
|
Teva Pharmaceutical Industries Ltd -- Moody's says Teva's US generics business will face increased price pressure in 2018; a credit negative
Announcement: Moody's says Teva's US generics business will face increased price pressure in 2018; a credit negative